Transport of topoisomerase I inhibitors by the breast cancer resistance protein - Potential clinical implications

MLA

Schellens, Jhm, et al. Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein - Potential Clinical Implications. Jan. 2000. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........1b4ed4338f0de0d57919a0a6572b0d1c&authtype=sso&custid=ns315887.

APA

Schellens, J., Maliepaard, M., Scheper, R., Scheffer, G., Jonker, J., Smit, J., Beijnen, J., Schinkel, A., Liehr, J., Giovanella, B., & Verschaegen, C. (2000). Transport of topoisomerase I inhibitors by the breast cancer resistance protein - Potential clinical implications.

Chicago

Schellens, Jhm, M Maliepaard, Rj Scheper, Gl Scheffer, Jw Jonker, Jw Smit, Jh Beijnen, et al. 2000. “Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein - Potential Clinical Implications,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........1b4ed4338f0de0d57919a0a6572b0d1c&authtype=sso&custid=ns315887.